Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments
Philips (NYSE: PHG) and Medtronic Neurovascular announced a strategic advocacy partnership to improve stroke care access globally. Both companies joined the newly established World Stroke Organization (WSO) Advocacy Coalition, focusing on three key areas: raising public awareness of stroke symptoms, improving treatment access, and leveraging technology for integrated care systems.
The partnership addresses a critical health issue affecting 12 million people annually, with direct and indirect costs estimated at USD 900 billion, expected to double in 25 years. The collaboration aims to develop a global network of comprehensive stroke care centers and will be highlighted at the upcoming World Stroke Congress in Abu Dhabi.
Philips (NYSE: PHG) e Medtronic Neurovascular hanno annunciato una partnership strategica di advocacy per migliorare l'accesso alle cure per ictus a livello globale. Entrambe le aziende si sono unite alla nuovissima World Stroke Organization (WSO) Advocacy Coalition, concentrandosi su tre aree chiave: aumentare la consapevolezza pubblica sui sintomi dell'ictus, migliorare l'accesso al trattamento e sfruttare la tecnologia per sistemi di cura integrati.
La partnership affronta una questione sanitaria critica che colpisce 12 milioni di persone all'anno, con costi diretti e indiretti stimati a 900 miliardi di dollari, che dovrebbero raddoppiare in 25 anni. La collaborazione mira a sviluppare una rete globale di centri di cura per ictus completi e sarà messa in evidenza al prossimo World Stroke Congress di Abu Dhabi.
Philips (NYSE: PHG) y Medtronic Neurovascular anunciaron una asociación estratégica de defensa para mejorar el acceso a la atención del ictus a nivel mundial. Ambas compañías se unieron a la recién establecida World Stroke Organization (WSO) Advocacy Coalition, enfocándose en tres áreas clave: aumentar la conciencia pública sobre los síntomas del ictus, mejorar el acceso al tratamiento y aprovechar la tecnología para sistemas de atención integrados.
La asociación aborda un problema de salud crítica que afecta a 12 millones de personas anualmente, con costos directos e indirectos estimados en 900 mil millones de dólares, que se espera que se dupliquen en 25 años. La colaboración tiene como objetivo desarrollar una red global de centros de atención integral para el ictus y se destacará en el próximo World Stroke Congress en Abu Dhabi.
Philips (NYSE: PHG)와 Medtronic Neurovascular는 전 세계적으로 뇌졸중 치료 접근성을 개선하기 위해 전략적 옹호 파트너십을 발표했습니다. 두 회사는 최근에 설립된 세계 뇌졸중 기구 (WSO) 옹호 연합에 참여하여, 뇌졸중 증상에 대한 대중 인식 높이기, 치료 접근성 개선, 통합 치료 시스템을 위한 기술 활용의 세 가지 주요 분야에 집중하고 있습니다.
이 파트너십은 매년 1200만 명에 영향을 미치는 중요한 건강 문제를 다루며, 직접 및 간접 비용은 약 9000억 달러로 추정되며, 25년 안에 두 배로 증가할 것으로 예상됩니다. 이 협력은 전 세계 포괄적인 뇌졸중 치료 센터 네트워크를 개발하는 것을 목표로 하며, 아부다비에서 열리는 세계 뇌졸중 학회에서 강조될 것입니다.
Philips (NYSE: PHG) et Medtronic Neurovascular ont annoncé un partenariat stratégique de plaidoyer pour améliorer l'accès aux soins d'AVC à l'échelle mondiale. Les deux entreprises ont rejoint la nouvelle Coalition de plaidoyer de l'Organisation mondiale de l'AVC (WSO), en se concentrant sur trois domaines clés : sensibiliser le public aux symptômes de l'AVC, améliorer l'accès aux traitements et tirer parti de la technologie pour des systèmes de soins intégrés.
Ce partenariat aborde une question de santé cruciale touchant 12 millions de personnes chaque année, avec des coûts directs et indirects estimés à 900 milliards de dollars, qui devraient doubler dans 25 ans. La collaboration vise à développer un réseau mondial de centres de soins de l'AVC complets et sera mise en avant lors du prochain World Stroke Congress à Abou Dabi.
Philips (NYSE: PHG) und Medtronic Neurovascular haben eine strategische Partnerschaft zur Advocacy angekündigt, um den Zugang zu Schlaganfallbehandlungen weltweit zu verbessern. Beide Unternehmen sind der neu gegründeten World Stroke Organization (WSO) Advocacy Coalition beigetreten, die sich auf drei Schlüsselbereiche konzentriert: das Bewusstsein der Öffentlichkeit für Schlaganfallsymptome zu erhöhen, den Zugang zu Behandlungen zu verbessern und Technologie für integrierte Versorgungssysteme zu nutzen.
Die Partnerschaft greift ein kritisches Gesundheitsproblem auf, das jährlich 12 Millionen Menschen betrifft, wobei die direkten und indirekten Kosten auf schätzungsweise 900 Milliarden US-Dollar beziffert werden, die sich in 25 Jahren verdoppeln sollen. Die Zusammenarbeit zielt darauf ab, ein globales Netzwerk von umfassenden Schlaganfallzentren zu entwickeln und wird auf dem kommenden World Stroke Congress in Abu Dhabi hervorgehoben.
- Partnership with Medtronic Neurovascular strengthens market position in stroke care
- Joining WSO Advocacy Coalition expands global reach and influence
- Addresses a large market with USD 900 billion in annual costs
- None.
Insights
This strategic advocacy partnership between Philips and Medtronic Neurovascular represents a significant development in global stroke care infrastructure. The collaboration targets a market worth approximately
The partnership's integration with the WSO Advocacy Coalition adds institutional backing and potentially accelerates market penetration in developing regions. While immediate financial impact may be , the long-term strategic positioning in the growing stroke care market, affecting 12 million people annually, presents significant revenue opportunities through increased adoption of their diagnostic and treatment technologies.
The partnership strategically positions both companies to capitalize on the expanding stroke care infrastructure market. Key technological initiatives include advanced imaging systems and digital health tools for integrated stroke care, which could drive adoption of both companies' product portfolios. This collaboration particularly strengthens Philips' position in diagnostic imaging and Medtronic's in neurovascular therapies, creating potential synergies in product development and market access.
The focus on comprehensive care centers presents opportunities for increased sales of high-margin medical devices and imaging systems. The emphasis on training healthcare professionals in interventional techniques could accelerate market penetration of both companies' advanced medical technologies.
October 24, 2024
Both companies also join the newly established World Stroke Organization Advocacy Coalition
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke care is crucial to saving lives and reducing long-term disability. As leaders in stroke diagnosis and treatment, the two organizations are advocating on raising awareness around the potential health and economic benefits for patients, their families and societies of improving access to timely stroke diagnosis and treatment.
Philips and Medtronic Neurovascular also further expanded and strengthened their partnerships with the World Stroke Organization (WSO) by joining the newly established WSO Advocacy Coalition. This WSO-led coalition brings together diverse stakeholders, including healthcare professionals, patient groups, and policymakers, to develop coordinated strategies that address the global burden of stroke. The two companies are already working together with the World Stroke Organization to share the latest research, exchange best practices, drive improvements and advance the stroke policy agenda.
A stroke is typically an acute event, mostly caused by a blockage in a blood vessel in the brain that prevents adequate blood supply to brain tissue and leads to permanent loss of brain cells. It is a leading cause of disability and death worldwide, affecting an estimated 12 million people globally every year, including an increasing number of young people. The direct and indirect costs are conservatively estimated to be around USD 900 billion annually and are expected to almost double over the next 25 years.
Philips and Medtronic Neurovascular are advocating for a global network of stroke care centers that can deliver comprehensive care, from early diagnosis to rehabilitation. Their joint efforts focus on three key areas:
- Raising awareness: Promoting public understanding of stroke symptoms and the importance of seeking immediate care.
- Improving access to treatment: Expanding the number of stroke-ready hospitals and providing training to healthcare professionals on the latest interventional techniques.
- Leveraging technology and innovation: Utilizing advanced imaging and digital health tools to create integrated stroke care systems that support early diagnosis, effective treatment, and post-procedure monitoring.
The collaboration will be highlighted at the upcoming World Stroke Congress (October 23-26) in Abu Dhabi, where Philips and Medtronic Neurovascular will host a Stroke Advocacy roundtable session. This initiative builds on their joint presence at events such as the United Nations General Assembly and the World Health Assembly, where they emphasized the need for increased investments in stroke care infrastructure and supportive policy changes.
“Our new partnership with Medtronic Neurovascular and the ongoing collaboration with the World Stroke Organization highlights our shared commitment to transforming stroke care. With advanced technologies and a focus on collaboration, the time to act is now to ensure that stroke patients have timely stroke care — no matter where they live,” said Carla Goulart Peron, Chief Medical Officer, Philips.
“Stroke care is a race against time, and by joining forces with Philips, we can help accelerate access to life-saving treatments like mechanical thrombectomy. Together, we are advocating for necessary investments in stroke care infrastructure to reduce the burden on patients and healthcare systems globally,” said Signe Haughton, Chief of Staff, Senior Director of Medical & Government Affairs, Medtronic Neurovascular.
WSO Advocacy Coalition
Philips’ partnership with the World Stroke Organization, established in 2023, has now been further expanded and strengthened by Philips’ involvement in the WSO Advocacy Coalition. While the initial partnership focused on improving access to high-quality stroke care globally, this new collaboration deepens Philips' role in global stroke advocacy. By joining the WSO Advocacy Coalition, Philips is now part of a global network that actively works on healthcare policy, raise public awareness, and advocate for increased investment in stroke care infrastructure.
[1] World Stroke Organization - Time for a Revolution in Stroke Care
[2] The Lancet Neurology - Pragmatic solutions to reduce the global burden of stroke
For further information, please contact:
Joost Maltha
Philips External Relations
Tel. : +31 6 10558116
E-mail : joost.maltha@philips.com
Kelli Lynch
Medtronic Public Relations
Tel.: + 1 203-500-3328
E-mail: Kelli.b.lynch@medtronic.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow on LinkedIn.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Attachments
FAQ
What is the purpose of Philips (PHG) and Medtronic's new advocacy partnership?
What is the current global impact of stroke according to Philips (PHG) press release?
What are the three key focus areas of Philips (PHG) and Medtronic's stroke care initiative?
